ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Fisher Seeks Damages Under Privacy Act; NIH Consents To Remove Database Flags

March 10, 1995

Conference Level For NCI Is 5.4% Over FY 1990

November 2, 1990

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

ASCO Awards Contract For D.C Office

January 12, 1990

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

Group Chairman Balk At Board’s Recommendations

February 15, 1980